Origins of G1 arrest in senescent human fibroblasts
The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
Human diploid fibroblasts have a finite proliferative lifespan in culture, at the end of which they are ararrested with G 1 phase DNA contents. Upon serum stimulation, senescent cells are deficient in carrying out a subset of early signal transduction events such as activation of protein kinase C and induction of c‐fos. Later in G 1, they uniformly fail to express late G 1 genes whose products are required for DNA synthesis, implying that they are unable to pass the R point. Failure to pass the R point may occur because senescent cells are unable to phosphorylate the retinoblastoma protein, owing to the accumulation of inactive complexes of cyclin E/Cdk2 and possibly cyclin D/Cdk4. Senescent cells contain high amounts of p21, a potent cyclin‐dependent kinase inhibitor whose levels are also elevated in cells arrested in G 1 following DNA damage, suggesting that both arrests might share a common mechanism. Cell aging is accompanied by a progressive shortening of chromosomal telomeres, which could be perceived by the cells as a form of DNA damage that gives rise to the signals that inactivate the cell cycle machinery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Originally, cellular senescence was defined as an irreversible arrest in the G1 phase of the cell cycle (reviewed in refs.25,26 ).”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [25]
In the citing paper
“Originally, cellular senescence was defined as an irreversible arrest in the G1 phase of the cell cycle (reviewed in refs.25,26 ).”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [25]
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Research works printed but not linked: 3
- Martin G. M., 1970, Replicative life‐span of cultivated human cells, Lab. Invest., 23, 86
- Pignolo R. J., 1990, Altered expression of AP‐1 binding activity but not c‐jun or junB mRNA expression in senescent WI‐38 cells, J. Cell Biol., 111, 498a
- Pringle J. P., 1981, The Molecular Biology of the Yeast Saccaharomyces, 97
Cited by
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
“Cells transduced with cease proliferation at subconfluent densities despite the H-rasV12 or with empty vector were plated at low density presence of serum (reviewed by Stein and Dulic, 1995; and cell numbers were counted (Figure 2B; data not Votja and Barrett, 1995).”
BackgroundMethodThe p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Stein, G. H., Drullinger, L. F., Soulard, A., & Dulić, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2109 · Cited by 868
Self-citationRegulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
“, by interfering with p53 function (56).”
Niculescu, A. B., Chen, X., Smeets, M., Hengst, L., Prives, C., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.629 · Cited by 724
“p21 is also induced in fibroblasts as a consequence of clonal senescence (51, 69).”
BackgroundRas Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species
Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T., Yu, Z.-X., Ferrans, V. J., Howard, B. H., & Finkel, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7936 · Cited by 691
Radiation-induced cell death mechanisms
Eriksson, D., & Stigbrand, T. (2010) · Tumor Biology · doi:10.1007/s13277-010-0042-8 · Cited by 666
“Senescent cells display characteristic phenotypic traits as they become enlarged and flattened with an increased granularity [119, 120 ].”
BackgroundWang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
“At a population doubling level (PDL) of ∼55–60, vector-containing HMECs ceased proliferation , adopted a senescent morphology (for review , see Stein and Dulic 1995), and stained positive for senescence-associated -galactosidase (Dimri et al. 1995; Fig.”
Backgroundp16 INK4A is a robust in vivo biomarker of cellular aging in human skin
Ressler, S., Bartkova, J., Niederegger, H., Bartek, J., Scharffetter‐Kochanek, K., Jansen‐Dürr, P., & Wlaschek, M. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00231.x · Cited by 557
“Studies of replicative senescence have focused on the fact that senescent cells in vitro undergo growth arrest in the G1 phase of the cell cycle (Stein & Dulic, 1995) mediated by a series of inhibitors of cell-cycle-dependent kinases, required for progression from G1 to S-phase (Sherr & Roberts,…”
BackgroundReplicative Senescence: Implications for in Vivo Aging and Tumor Suppression
Smith, J. R., & Pereira-Smith, O. M. (1996) · Science · doi:10.1126/science.273.5271.63 · Cited by 547
Senescent cell clearance by the immune system: Emerging therapeutic opportunities
Prata, L. G. P. L., Ovsyannikova, I. G., Tchkonia, T., & Kirkland, J. L. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.003 · Cited by 497
What is the restriction point?
Zetterberg, A., Larsson, O., & Wiman, K. G. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80067-0 · Cited by 351
The Tumor Suppressor Protein p16INK4a
SERRANO, M. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3824 · Cited by 346
Durand, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.306 · Cited by 325
“…for accumulation of Cdk inhibitors may be responsible (Noda either arresting the cell cycle or initiating differentiation. et al., 1994; reviewed in Stein and Dulic, 1995), and An increase in p27 has also been associated with recent evidence suggests a role for p16Ink4 (Hara et al., cell cycle…”
BackgroundResultInfluentialMcConnell, B. B., Starborg, M., Brookes, S., & Peters, G. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70137-x · Cited by 314
Senescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300
“Originally, cellular senescence was defined as an irreversible arrest in the G1 phase of the cell cycle (reviewed in refs.(25,26)).”
BackgroundSelf-citationCasaccia-Bonnefil, P., Tikoo, R., Kiyokawa, H., Friedrich, V., Chao, M. V., & Koff, A. (1997) · Genes & Development · doi:10.1101/gad.11.18.2335 · Cited by 252
“This is reminiscent of cells undergoing a programmed senescence and suggests that those proteins involved in senescence, such as p21 and p16 (Noda et al. 1994; Stein and Dulic 1995; Tahara et al. 1995; Hara et al. 1996), may play a greater role in the establishment of”
BackgroundInfluentialHUTTER, E., RENNER, K., PFISTER, G., STÖCKL, P., JANSEN-DÜRR, P., & GNAIGER, E. (2004) · Biochemical Journal · doi:10.1042/bj20040095 · Cited by 235
“To investigate age-related alterations of mitochondria in diploid human fibroblasts, mitochondrial respiratory function in young and senescent fibroblasts was analysed in a standardized experimental regime (Figure 1). Since senescent fibroblasts are irreversibly arrested in the G1 phase of the cell cycle [ 28 ], young…”
Betz, B. L., Strobeck, M. W., Reisman, D. N., Knudsen, E. S., & Weissman, B. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205706 · Cited by 212
“The morphologic and biochemical features of hSNF5 arrested cells closely resemble those observed during cellular senescence, an irreversible growth arrest induced by cumulative cell divisions (Smith and Pereira-Smith, 1996; Stein and Dulic, 1995).”
BackgroundThe role of senescence and immortalization in carcinogenesis
Reddel, R. R. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.477 · Cited by 212
Wagner, M., Hampel, B., Bernhard, D., Hala, M., Zwerschke, W., & Jansen-Dürr, P. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00105-x · Cited by 203
Pantoja, C., & Serrano, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202880 · Cited by 201
“In particular, there is strong evidence implicating the tumor suppressors p53 and p16INK4a in senescence (reviewed in Stein and Dulic, 1995; Garkavtsev et al., 1998).”
BackgroundVascular smooth muscle cell senescence in atherosclerosis
GORENNE, I., KAVURMA, M., SCOTT, S., & BENNETT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.004 · Cited by 196
“In order to maintain stability, plaque caps require greater collagen and ECM content than the adjacent intima [3].”
Cellular senescence in the aging and diseased kidney
Valentijn, F. A., Falke, L. L., Nguyen, T. Q., & Goldschmeding, R. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0434-2 · Cited by 173
“Senescence has typically been linked to the G1-phase of the cell-cycle, but it does occur also in G2 (see below) (Stein and Dulić 1995; Smith and Pereira-Smith 1996).”
BackgroundWick, G., Jansen‐Dürr, P., Berger, P., Blasko, I., & Grubeck‐Loebenstein, B. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00489-2 · Cited by 176
Uncoupling between Phenotypic Senescence and Cell Cycle Arrest in Aging p21-Deficient Fibroblasts
Dulić, V., Beney, G.-E., Frebourg, G., Drullinger, L. F., & Stein, G. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6741-6754.2000 · Cited by 149
“These phenotypic changes include altered morphology, increased cell volume, expression of a neutral senescence-associated b-galactosidase activity (SA–b-Gal), and increased production of extracellular matrix degradative enzymes such as collagenase and stromelysin (26, 40, 61).”
BackgroundSelf-citationHaq, R., Brenton, J. D., Takahashi, M. T., Finan, D., Finkielsztein, A., Damaraju, S., Rottapel, R. K., & Zanke, B. W. (2002) · PubMed · Cited by 165
When dormancy fuels tumour relapse
Santos-de-Frutos, K., & Djouder, N. (2021) · Communications Biology · doi:10.1038/s42003-021-02257-0 · Cited by 165
The role of cyclin E in cell proliferation, development and cancer
Keyomarsi, K., & Herliczek, T. W. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_14 · Cited by 151
Yoon, I. K., Kim, H. K., Kim, Y. K., Song, I.-H., Kim, W., Kim, S., Baek, S.-H., Kim, J. H., & Kim, J.-R. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.07.002 · Cited by 123
“Thus, the downregulation of CENP-F and KIF4A in senescent cells might be partly ascribed to the defective cell cycle progression and reduced S and G2/M population of the cells (Stein and Dulic, 1995; Wagner et al., 2001).”
p27 KIP1 Blocks Cyclin E-Dependent Transactivation of Cyclin A Gene Expression
Zerfass-Thome, K., Schulze, A., Zwerschke, W., Vogt, B., Helin, K., Bartek, J., Henglein, B., & Jansen-Dürr, P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.407 · Cited by 119
“Nevertheless, cyclin E protein accumulates in physiological situations where cells do not enter S phase (13, 47); most likely, this reflects posttranslational control of cyclin E activity.”
BackgroundProsperi, E. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_15 · Cited by 128
Caffeine Inhibits Cell Proliferation by G0/G1 Phase Arrest in JB6 Cells
Hashimoto, T., He, Z., Ma, W.-Y., Schmid, P. C., Bode, A. M., Yang, C. S., & Dong, Z. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3453 · Cited by 115
“Cdk4/6 and cdk2 are key kinases, which phosphorylate pRb in the G0 to G1 and G1 to S transitions (29).”
BackgroundHo, H., Cheng, M., Lu, F., Chou, Y.-H., Stern, A., Liang, C., & Chiu, D. T.-Y. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00331-2 · Cited by 118
Mannhardt, B., WEINZIMER, S. A., Wagner, M., Fiedler, M., Cohen, P., Jansen‐Dürr, P., & Zwerschke, W. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6483-6495.2000 · Cited by 94
Lanahan, A., Lyford, G., Stevenson, G. S., Worley, P. F., & Barnes, C. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02876.1997 · Cited by 88
Shi, W., Hoeflich, A., Flaswinkel, H., Stojković, M., Wolf, E., & Zakhartchenko, V. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.012112 · Cited by 90
“These phenotypes are the features of cellular senescence [39, 40].”
BackgroundEllinger-Ziegelbauer, H., Kelly, K., & Siebenlist, U. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3857 · Cited by 85
“These features superficially resemble those of some terminally differentiated or senescent cells (50).”
BackgroundMunro, J., Steeghs, K., Morrison, V., Ireland, H., & Parkinson, E. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204460 · Cited by 91
“The p53 (Figure 5d) and p14ARF (Figure 5e) proteins did not increase in the LTC cultures, which is similar to results previously reported for senescent human ®broblasts (Vaziri et al., 1997; Robles and Adami, 1998), as is the decline in cyclin B1 levels (Figure 5f, see Stein and Dulic, 1995).”
ResultPhinney, D. G., Kopen, G. C., Isaacson, R. L., & Prockop, D. J. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990315)72:4<483::aid-jcb4>3.0.co;2-i · Cited by 551
Synthesis, Modification and Turnover of Proteins during Aging
Rattan, S. I. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7002-2_1 · Cited by 83
A Darwinian-evolutionary concept of age-related diseases
Wick, G., Berger, P., Jansen‐Dürr, P., & Grubeck‐Loebenstein, B. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00161-4 · Cited by 81
Yang, X., He, Z., Xin, B., & Cao, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203515 · Cited by 71
“Since senescence is thought to be a process that primary cells employed to stop proliferating and to irreversibly withdraw from cell cycle (Stein and Dulic, 1995), we suggest that in addition to stimulating cell growth, that the ability of LMP1 to suppress senescence is also important for…”
BackgroundInfluentialvan Heemst, D., den Reijer, P. M., & Westendorp, R. G. J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.011 · Cited by 87
Hütter, E., Unterluggauer, H., Überall, F., Schramek, H., & Jansen‐Dürr, P. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00136-5 · Cited by 68
Clark, E., Santiago, F., Deng, L., Chong, S. Y., de la Fuente, C., Wang, L., Fu, P., Stein, D., Denny, T. N., Lanka, V. K., et al. (2000) · Journal of Virology · doi:10.1128/.74.11.5040-5052.2000 · Cited by 68
“Recruitment of resting cells into the cell cycle is controlled by a circuitry that interacts with the cell cycle machinery (16, 43).”
BackgroundMethodPrematurely senescent ARPE-19 cells display features of age-related macular degeneration
Glotin, A., Debacq‐Chainiaux, F., Brossas, J., Faussat, A., Tréton, J., Zubielewicz, A., Toussaint, O., & Mascarelli, F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.023 · Cited by 78
Sant, C. V., Kawaguchi, Y., & Roizman, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8184 · Cited by 68
C/EBPα Regulation of the Growth-Arrest-Associated Gene gadd45
Constance, C. M., Morgan, J. I., & Umek, R. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3878 · Cited by 62
“Human diploid fibroblasts enter an irreversible growth arrest state, senescence, after limited mitotic growth in culture (34).”
BackgroundOxidative DNA damage as a marker of aging in WI-38 human fibroblasts
Wolf, F. I., Torsello, A., Covacci, V., Fasanella, S., Montanari, M., Boninsegna, A., & Cittadini, A. R. M. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00005-0 · Cited by 63
Fournier, C., Wiese, C., & Taucher-Scholz, G. (2004) · Radiation Research · doi:10.1667/rr3182 · Cited by 66
“CDKN2A (formerly known as p16), are also involved in fibroblast differentiation (50, 51).”
BackgroundZuo, S., Liu, C., Wang, J., Wang, F., Xu, W., Cui, S., Yuan, L., Chen, X., Fan, W., Cui, M., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1153-y · Cited by 58
“Senescent cells arrest growth, usually with a DNA content that is typical of G1 phase (Stein and Dulic 1995).”
Moderate hyperoxia induces senescence in developing human lung fibroblasts
You, K., Parikh, P., Khandalavala, K., Wicher, S. A., Manlove, L., Yang, B., Roesler, A., Roos, B. B., Teske, J. J., Britt, R. D., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00067.2019 · Cited by 59
“This result is inconsistent with the concept that cellular senescence is due to an irreversible arrest in the G1 phase of the cell cycle (46, 47).”
ResultPalmieri, D., Watson, J. M., & Rinehart, C. A. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4341 · Cited by 60
p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
Fujita, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236023 · Cited by 56
Bai, P., Xiao, X., Zou, J., Cui, L., Nguyen, T. M. B., Liu, J., Xiao, J., Chang, B., Wu, J., & Wang, H. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.523 · Cited by 55
“The definition of senescence is a process that keeps the stable form of cell cycle arrest at the G 1 phase (5), as first reported by Hayflick (6).”
Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model
Carnero, A., Hudson, J. D., Hannon, G. J., & Beach, D. H. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.11.2234 · Cited by 59
Regulation of p53 during senescence in normal human keratinocytes
Kim, R. H., Kang, M., Kim, T., Yang, P., Bae, S., Williams, D. W., Phung, S., Shin, K., Hong, C., & Park, N. (2015) · Aging Cell · doi:10.1111/acel.12364 · Cited by 54
“Compared to NHFs, the expression level of p53 is significantly higher in actively proliferating NHKs. Previous studies reported that high level of p53 was progressively decreased during the replicative senescence in NHKs (Kim et al., 2010; Sisoula et al., 2010; Wilson et al., 2010), indicating that…”
Ageing—A biological perspective
Rattan, S. I. S. (1995) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(95)00005-2 · Cited by 52
Fan, W. Q., Sun, L., Zhou, J.-Q., Zhang, C., Qin, S., Tang, Y., Yang, L. I. U., Lin, S., & Yuan, S. (2015) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(15)30036-4 · Cited by 54
Pignolo, R. J., Martin, B. G., Horton, J. H., Kalbach, A., & Cristofalo, V. J. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(97)00090-9 · Cited by 47
Molecular and cellular targets
Bode, A. M., & Dong, Z. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20222 · Cited by 58
Regulation of replicative senescence by NADP+-dependent isocitrate dehydrogenase
Kil, I. S., Huh, T. L., Lee, Y. S., Lee, Y. M., & Park, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.021 · Cited by 44
Dulic, V. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_2 · Cited by 42
Novoa, B., Pereiro, P., López‐Muñoz, A., Varela, M., Forn‐Cuní, G., Anchelin, M., Dios, S., Romero, A., Martinez‐López, A., Medina‐Gali, R. M., et al. (2019) · Aging Cell · doi:10.1111/acel.13020 · Cited by 41
Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis
Kelich, J. M., Aramburu, T. M., van der Vis, J. J., Showe, L. C., Kossenkov, A. V., van der Smagt, J. J., Massink, M. P. G., Schoemaker, A. E., Hennekam, E. A. M., Veltkamp, M., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211681 · Cited by 46
“…/article-pdf/219/5/e20211681/1431700/jem _20211681.pdf by guest on 14 April 2022 Mutations within key telomeric genes, including TERT, TERC, DKC1 (dyskerin), RTEL1, PARN, and TINF2 (TIN2) have been implicated in IPF, a chronic disease affecting the lungs (Stuart et al., 2015; Hoffman et al., 2016).”
BackgroundHsieh, J.-K., Kletsas, D., Clunn, G. F., Hughes, A. D., Schächter, M., & Demoliou-Mason, C. D. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.636 · Cited by 42
p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells
Unnikrishnan, I., Radfar, A., Jenab-Wolcott, J., & Rosenberg, N. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4825 · Cited by 43
Histone deacetylases in replicative senescence: evidence for a senescence‐specific form of HDAC‐2
Wagner, M., Brosch, G., Zwerschke, W., Seto, E., Loidl, P., & Jansen‐Dürr, P. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02524-8 · Cited by 46
Progeroid syndromes: probing the molecular basis of aging?
Kipling, D., & Faragher, R. (1997) · Molecular Pathology · doi:10.1136/mp.50.5.234 · Cited by 46
Parkinson, E. K., Newbold, R. F., & Keith, W. N. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00063-4 · Cited by 39
Optimization of immunolocalization of cell cycle proteins in human corneal endothelial cells.
Hé, Z., Campolmi, N., THI, B. H., Dumollard, J., Péoc’h, M., Garraud, O., Piselli, S., Gain, P., & Thuret, G. (2011) · PubMed Central · Cited by 50
E2Fs and the Retinoblastoma Protein Family
Sardet, C., Cam, L. L., Fabbrizio, E., & Vidal, M. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8934-6_1 · Cited by 37
Wagner, M., Hampel, B., Hütter, E., Pfister, G., Krek, W., Zwerschke, W., & Jansen‐Dürr, P. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00165-6 · Cited by 32
Telomeres, senescence and cellular radiation response
Crompton, N. E. A. (1997) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050073 · Cited by 32
Targeted Radionuclide Tumor Therapy
Stigbrand, T. I., Adams, G. P., & Carlsson, J. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8696-0 · Cited by 32
Subburayan, K., Thayyullathil, F., Pallichankandy, S., Rahman, A. U., & Galadari, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.009 · Cited by 34
Citrus hystrix Extracts Protect Human Neuronal Cells against High Glucose-Induced Senescence
Pattarachotanant, N., & Tencomnao, T. (2020) · Pharmaceuticals · doi:10.3390/ph13100283 · Cited by 30
“In replicatively senescent cells, the cell cycle is arrested at the G1 and/or G2 phase [6,7].”
BackgroundA transcriptional roadmap to the senescence and differentiation of human oral keratinocytes.
Jang, D., Bhawal, U., Min, H., Kang, H. K., Abiko, Y., & Min, B.-M. (2015) · The journals of gerontology. Series A, Biological sciences and medical sciences · doi:10.1093/gerona/glt212 · Cited by 26
“Senescent cells have an arrested cell cycle at G1 (11) and upregulate the cell cycle inhibitor p16 (12,13).”
BackgroundAlternative product of the p16/CKDN2A locus connects the Rb and p53 tumor suppressors
James, M. C., & Peters, G. G. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4253-7_7 · Cited by 31
Hsieh, J.-K., Kletsas, D., Clunn, G. F., Hughes, A. D., Schächter, M., & Demoliou-Mason, C. D. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.973 · Cited by 32
Lee, G., Park, B. S., Han, S. E., Oh, J.-E., You, Y., Baek, J., Kim, G.-S., & Min, B. (2000) · Archives of Oral Biology · doi:10.1016/s0003-9969(00)00061-3 · Cited by 25
Hashimoto, Y., Kohri, K., Akita, H., Mitani, K., Ikeda, K., & Nakanishi, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7534 · Cited by 24
Vitamin E Supplementation Delays Cellular SenescenceIn Vitro
Fata, G. L., Seifert, N., Weber, P., & Mohajeri, M. H. (2015) · BioMed Research International · doi:10.1155/2015/563247 · Cited by 27
“In agreement with previous reports [4, 17, 19, 27, 28] we observe a significant increase of SA-𝛽 -gal positive cells, including altered cell morphology, reduced proliferation rate, and overexpression of the P16 and P21 genes in HUVEC cultures at late passages (Figure 1 and Supplementary Figure 1 ).”
PHF10 Is Required for Cell Proliferation in Normal and SV40-Immortalized Human Fibroblast Cells
Banga, S. S., Peng, L., Dasgupta, T., Palejwala, V. A., & Ozer, H. L. (2009) · Cytogenetic and Genome Research · doi:10.1159/000251960 · Cited by 24
“These cells normally undergo 50–60 cell divisions, after which they stop dividing and enter a state of ‘replicative senescence’, with arrest within the G1 stage of the cell cycle [Stein and Dulic, 1995; Smith and PereiraSmith, 1996].”
BackgroundApoptosis in stress-induced and spontaneously senescent human fibroblasts
Ohshima, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.044 · Cited by 27
Yao, Z., Gallez-Hawkins, G. M., Lomeli, N. A., Li, X., Molinder, K. M., Diamond, D. J., & Zaia, J. A. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00423-0 · Cited by 23
Effect of Antioxidants on the Fibroblast Replicative Lifespan In Vitro
Sadowska‐Bartosz, I., & Bartosz, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6423783 · Cited by 24
“Human fibroblasts arrest in the G1 phase of the cell cycle upon entering the senescent state [24].”
BackgroundHala, M., Hartmann, B. L., Böck, G., Geley, S., & Kofler, R. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961127)68:5<663::aid-ijc17>3.0.co;2-2 · Cited by 66
Kim, J., Lee, H. L., Jeong, J. H., Yoon, Y. E., Lee, I.-R., Kim, J. M., Wu, C., & Lee, S. (2022) · Antioxidants · doi:10.3390/antiox11112180 · Cited by 23
“p21 is involved in cell cycle arrest in the G1 phase of senescent cells [46].”
Defining and characterizing neuronal senescence, ‘neurescence’, as GX arrested cells
Hudson, H. R., Rießland, M., & Orr, M. E. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.09.006 · Cited by 26
Wang, H.-H., Lee, Y., Su, C., Shu, K.-T., Liu, W., Hsieh, C., Yeh, H., & Wu, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-63716-y · Cited by 21
A drug-induced accelerated senescence (DIAS) is a possibility to study aging in time lapse
Alili, L., Diekmann, J., Giesen, M., Holtkötter, O., & Brenneisen, P. (2014) · AGE · doi:10.1007/s11357-014-9658-8 · Cited by 21
La sénescence cellulaire: Un nouveau mythe de Janus ?
Brondello, J., Prieur, A., Philipot, D., Lemaître, J.-M., Lenaers, G., Piette, J., & Dulić, V. (2012) · médecine/sciences · doi:10.1051/medsci/2012283017 · Cited by 31
“La sénescence est étroitement associée à l’inactivation des kinases dépendantes des cyclines (CDK), principaux régulateurs du cycle cellulaire [4].”
BackgroundSelf-citationXin, B., He, Z., Yang, X., Chan, C.-P., Ng, M., & Cao, L. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.3010-3015.2001 · Cited by 18
“The MEF-LNSX control cells were large and flat, reminiscent of replicative senescence (36).”
BackgroundAnticancer Therapy Targeting Telomeres and Telomerase: Current Status
Parkinson, E. K., & Minty, F. (2007) · BioDrugs · doi:10.2165/00063030-200721060-00005 · Cited by 22
Mohiuddin, M., & Kasahara, K. (2021) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20273 · Cited by 21
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Buontempo, F., Orsini, E., Zironi, I., Isolan, L., Cappellini, A., Rapino, S., Tartari, A., Mostacci, D., Cucchi, G., Martelli, A. M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199312 · Cited by 17
RetractedZhang, Y., Guo, L., Xing, P., Chen, Y., Li, F., Zhu, W., & Lu, X. (2014) · Europe PMC (PubMed Central) · Cited by 14
Metadata
- Authors
- Stein, G. H., & Dulić, V.
- Affiliations
- University of Colorado Boulder (US)
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Dulić, Vjekoslav
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 1995-06
- Volume
- 17
- Issue
- 6
- Pages
- 537-543
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W2013576756
- Cited by
- 135
- References
- 66
- Citations by year
- 2026: 2 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 1 · 2012: 5
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- BioEssays (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG 00947)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, G1 cell cycle arrest, human diploid fibroblasts, replicative lifespan, retinoblastoma protein phosphorylation, cyclin E/CDK2, p21, c-fos, protein kinase C, telomere shortening, DNA damage response, cell cycle regulation
- MeSH terms
- Cell Cycle, DNA, DNA Damage, Fibroblasts, Humans, Models, Biological, G1 Phase, Cyclins, Cellular Senescence, Cyclin-Dependent Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.